Clinical trial

A Randomized Control Trial Comparing Linjeta Versus Humalog in Pumps: Effect on Postprandial Blood Sugars.

NCT01067118

StatusWITHDRAWN

Study typeINTERVENTIONAL

Start date2010-04-01

PhasePHASE2

Study timeline

Study start (unknown)2010-04-01Date precision: month

Registry last updated2017-02-10

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Diabetes Mellitusunresolved

Interventions

LINjeta U-100 InsulinDRUG

Humalog U-100DRUG

Sponsors & collaborators

Stanford Universitylead sponsor

Biodelcollaborator

University of Colorado, Denvercollaborator

Mapped research locations

DenverColorado, United States1 StanfordCalifornia, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01067118 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.